Wealthstreet Investment Advisors LLC lessened its holdings in UnitedHealth Group Inc (NYSE:UNH) by 0.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 54,945 shares of the healthcare conglomerate’s stock after selling 375 shares during the quarter. UnitedHealth Group accounts for approximately 2.1% of Wealthstreet Investment Advisors LLC’s investment portfolio, making the stock its 8th biggest position. Wealthstreet Investment Advisors LLC’s holdings in UnitedHealth Group were worth $14,658,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in UNH. Ipswich Investment Management Co. Inc. bought a new stake in UnitedHealth Group during the fourth quarter worth about $40,000. OLD Second National Bank of Aurora raised its stake in UnitedHealth Group by 70.0% during the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after acquiring an additional 70 shares in the last quarter. Contravisory Investment Management Inc. raised its stake in UnitedHealth Group by 172.1% during the fourth quarter. Contravisory Investment Management Inc. now owns 185 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 117 shares in the last quarter. CX Institutional raised its stake in UnitedHealth Group by 475.0% during the fourth quarter. CX Institutional now owns 322 shares of the healthcare conglomerate’s stock worth $80,000 after acquiring an additional 266 shares in the last quarter. Finally, NewSquare Capital LLC raised its stake in UnitedHealth Group by 15.6% during the fourth quarter. NewSquare Capital LLC now owns 333 shares of the healthcare conglomerate’s stock worth $83,000 after acquiring an additional 45 shares in the last quarter. 90.80% of the stock is owned by institutional investors.
Several research analysts have commented on UNH shares. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, January 11th. Bank of America upped their price objective on UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research note on Wednesday, October 17th. Raymond James upped their price objective on UnitedHealth Group from $304.00 to $310.00 and gave the company a “strong-buy” rating in a research note on Wednesday, October 17th. Argus upped their price objective on UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a research note on Monday, December 17th. Finally, Stephens began coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective for the company. One investment analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $297.80.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of $260.55, for a total transaction of $3,908,250.00. Following the transaction, the director now directly owns 193,872 shares in the company, valued at approximately $50,513,349.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total value of $1,333,050.00. Following the transaction, the director now owns 77,702 shares in the company, valued at $20,716,130.22. The disclosure for this sale can be found here. Insiders have sold a total of 26,090 shares of company stock valued at $6,956,975 in the last three months. Insiders own 0.87% of the company’s stock.
NYSE:UNH traded down $3.23 on Monday, reaching $258.67. 1,157,279 shares of the stock traded hands, compared to its average volume of 3,539,171. The company has a market capitalization of $251.96 billion, a PE ratio of 20.08, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.69 and a current ratio of 0.73. UnitedHealth Group Inc has a 1-year low of $212.01 and a 1-year high of $287.94.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, beating analysts’ consensus estimates of $3.20 by $0.08. The business had revenue of $58.42 billion during the quarter, compared to the consensus estimate of $58.01 billion. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.59 EPS. Research analysts predict that UnitedHealth Group Inc will post 14.62 EPS for the current year.
WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2019/02/11/wealthstreet-investment-advisors-llc-has-14-66-million-stake-in-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Are Wall Street analysts’ stock ratings worth following?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.